` SAGE (SAGE Therapeutics Inc) vs PNEXF (Pharnext SCA) Comparison - Alpha Spread

SAGE
vs
PNEXF

Over the past 12 months, SAGE has underperformed PNEXF, delivering a return of -15% compared to the PNEXF's 0% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
SAGE
PNEXF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

SAGE Intrinsic Value
21.15 USD
Undervaluation 57%
Intrinsic Value
Price
PNEXF Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
SAGE Therapeutics Inc
NASDAQ:SAGE
9.2 USD
Pharnext SCA
OTC:PNEXF
999 999.9999 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
SAGE vs PNEXF

SAGE
PNEXF
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
SAGE Therapeutics Inc
Revenue
Pharnext SCA
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
SAGE vs PNEXF

SAGE
PNEXF
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
SAGE Therapeutics Inc
NASDAQ:SAGE
Pharnext SCA
OTC:PNEXF
What is Free Cash Flow?

Gross Margin

SAGE
81.4%
PNEXF
0%
LTM 3Y Avg 5Y Avg 10Y Avg
SAGE Therapeutics Inc
Pharnext SCA

Operating Margin

SAGE
-759%
PNEXF
-17 526.7%
LTM 3Y Avg 5Y Avg 10Y Avg
SAGE Therapeutics Inc
Pharnext SCA

Net Margin

SAGE
-747.6%
PNEXF
-21 040%
LTM 3Y Avg 5Y Avg 10Y Avg
SAGE Therapeutics Inc
Pharnext SCA

FCF Margin

SAGE
-656.3%
PNEXF
-15 953.3%
LTM 3Y Avg 5Y Avg 10Y Avg
SAGE Therapeutics Inc
Pharnext SCA

ROE

SAGE
-63.5%
PNEXF
114.6%
LTM 3Y Avg 5Y Avg 10Y Avg
SAGE Therapeutics Inc
Pharnext SCA

ROA

SAGE
-57.3%
PNEXF
-391.1%
LTM 3Y Avg 5Y Avg 10Y Avg
SAGE Therapeutics Inc
Pharnext SCA

ROIC

SAGE
-851.7%
PNEXF
3 092.9%
LTM 3Y Avg 5Y Avg 10Y Avg
SAGE Therapeutics Inc
Pharnext SCA

ROCE

SAGE
-63.9%
PNEXF
275.4%
LTM 3Y Avg 5Y Avg 10Y Avg
SAGE Therapeutics Inc
Pharnext SCA

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
SAGE vs PNEXF

Loading

Performance Gap
SAGE vs PNEXF

Loading
SAGE
PNEXF
Difference
www.alphaspread.com

Performance By Year
SAGE vs PNEXF

Loading
SAGE
PNEXF
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare SAGE to other stocks
Unlock Full Access to Alpha Spread
Create Free Account